Chippenham SN15 2BB
44 12 4946 6966
Branche: Drug Manufacturers—Specialty & Generic
|Mr. Andrew Timothy Franklin||Interim CEO, CFO & Exec. Director||271,52k||N/A||1966|
|Mr. Peter Jonathan Butterfield||CEO & Exec. Director (Leave of Absence)||399,83k||N/A||1976|
|Mr. Jeyan Heper (Hons), BA||COO & Director||N/A||N/A||N/A|
|Mr. Stephen Kidner||Chief Scientific Affairs Officer||N/A||N/A||N/A|
|Ms. Cora Maeve McCallum C.F.A.||Head of Investor Relations & Corp. Communications||N/A||N/A||N/A|
|Mr. Alex Duggan||Chief Commercial & Corp. Devel. Officer||N/A||N/A||N/A|
|Ms. Janice Timberlake||Chief People & Infrastructure Officer||N/A||N/A||N/A|
|Chris Delafield||Global Marketing Head of Kelo-Cote||N/A||N/A||N/A|
|Rhodri Smith||Head of Sourcing||N/A||N/A||N/A|
|Mr. Christodoulos Chrysanthou||Group Gen. Counsel & Company Sec.||N/A||N/A||N/A|
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. It provides its products under the Aloclair, Anbesol, Asthon and Parsons, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. Alliance Pharma plc was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Alliance Pharma plcs ISS Governance QualityScore, Stand N/A, lautet N/A. Die grundlegenden Scores sind Audit: N/A, Vorstand: N/A, Shareholderrechte: N/A, Kompensation: N/A.